The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Polymyalgia Rheumatica

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Polymyalgia Rheumatica


Psychiatry related information on Polymyalgia Rheumatica


High impact information on Polymyalgia Rheumatica


Chemical compound and disease context of Polymyalgia Rheumatica


Biological context of Polymyalgia Rheumatica

  • OBJECTIVE: To develop a rheumatology oriented questionnaire that measures compliance to drug regimen and identifies factors that contribute to suboptimal compliance in patients with rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), and gout [17].
  • RESULTS: No significant differences in allele or genotype frequencies for PTPN22 polymorphism were observed between patients with GCA and controls or when patients were stratified by presence of polymyalgia rheumatica (n = 38) or severe ischemic manifestations (n = 47) [18].

Anatomical context of Polymyalgia Rheumatica


Gene context of Polymyalgia Rheumatica


Analytical, diagnostic and therapeutic context of Polymyalgia Rheumatica


  1. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. Wagner, A.D., Goronzy, J.J., Weyand, C.M. J. Clin. Invest. (1994) [Pubmed]
  2. Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Wise, C.M., Agudelo, C.A., Chmelewski, W.L., McKnight, K.M. Arthritis Rheum. (1991) [Pubmed]
  3. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. Federici, A.B., Fox, R.I., Espinoza, L.R., Zimmerman, T.S. Arthritis Rheum. (1984) [Pubmed]
  4. Predictive value of radionuclide joint scintigrams. Shearman, J., Esdaile, J., Hawkins, D., Rosenthall, L. Arthritis Rheum. (1982) [Pubmed]
  5. Polymyalgia rheumatica and mitochondrial myopathy: clinicopathologic and biochemical studies in five cases. Harle, J.R., Pellissier, J.F., Desnuelle, C., Disdier, P., Figarella-Branger, D., Weiller, P.J. Am. J. Med. (1992) [Pubmed]
  6. Steroid dementia: an overlooked diagnosis? Sacks, O., Shulman, M. Neurology (2005) [Pubmed]
  7. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. Ma-Krupa, W., Jeon, M.S., Spoerl, S., Tedder, T.F., Goronzy, J.J., Weyand, C.M. J. Exp. Med. (2004) [Pubmed]
  8. Raised ESR in polymyalgia rheumatica no longer a sine qua non? Ortiz, Z., Tugwell, P. Lancet (1996) [Pubmed]
  9. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Pego-Reigosa, J.M., Rodriguez-Rodriguez, M., Hurtado-Hernandez, Z., Gromaz-Martin, J., Taboas-Rodriguez, D., Millan-Cachinero, C., Hernandez-Rodriguez, I., Gonzalez-Gay, M.A. Arthritis Rheum. (2005) [Pubmed]
  10. Vascular endothelial growth factor production in polymyalgia rheumatica. Meliconi, R., Pulsatelli, L., Dolzani, P., Boiardi, L., Macchioni, P., Salvarani, C., Silvestri, T., Frizziero, L., Facchini, A. Arthritis Rheum. (2000) [Pubmed]
  11. P-31 magnetic resonance spectroscopy demonstrates unaltered muscle energy utilization in polymyalgia rheumatica. Mattei, J.P., Bendahan, D., Erkintalo, M., Harle, J.R., Weiller, P.J., Roux, H., Cozzone, P.J. Arthritis Rheum. (1997) [Pubmed]
  12. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study. Mallya, R.K., Hind, C.R., Berry, H., Pepys, M.B. Arthritis Rheum. (1985) [Pubmed]
  13. The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica. Doury, P., Pattin, S., Eulry, F., Thabaut, A. Arthritis Rheum. (1983) [Pubmed]
  14. Treatment of polymyalgia rheumatica with intramuscular injections of depot methylprednisolone. Dasgupta, B., Gray, J., Fernandes, L., Olliff, C. Ann. Rheum. Dis. (1991) [Pubmed]
  15. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Straub, R.H., Glück, T., Cutolo, M., Georgi, J., Helmke, K., Schölmerich, J., Vaith, P., Lang, B. Rheumatology (Oxford, England) (2000) [Pubmed]
  16. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Martinez-Taboada, V.M., Bartolome, M.J., Fernandez-Gonzalez, M.D., Blanco, R., Rodriguez-Valverde, V., Lopez-Hoyos, M. Rheumatology (Oxford, England) (2003) [Pubmed]
  17. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. de Klerk, E., van der Heijde, D., van der Tempel, H., van der Linden, S. J. Rheumatol. (1999) [Pubmed]
  18. Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis. Gonzalez-Gay, M.A., Oliver, J., Orozco, G., Garcia-Porrua, C., Lopez-Nevot, M.A., Martin, J. J. Rheumatol. (2005) [Pubmed]
  19. Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate. Helfgott, S.M., Kieval, R.I. Arthritis Rheum. (1996) [Pubmed]
  20. Crowned dens syndrome misdiagnosed as polymyalgia rheumatica, giant cell arteritis, meningitis or spondylitis: an analysis of eight cases. Aouba, A., Vuillemin-Bodaghi, V., Mutschler, C., De Bandt, M. Rheumatology (Oxford, England) (2004) [Pubmed]
  21. Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica. Uddhammar, A., Rantapåå-Dahlqvist, S., Nilsson, T.K. Clin. Rheumatol. (1992) [Pubmed]
  22. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Weyand, C.M., Hunder, N.N., Hicok, K.C., Hunder, G.G., Goronzy, J.J. Arthritis Rheum. (1994) [Pubmed]
  23. In polymyalgia rheumatica serum prolactin is positively correlated with the number of typical symptoms but not with typical inflammatory markers. Straub, R.H., Georgi, J., Helmke, K., Vaith, P., Lang, B. Rheumatology (Oxford, England) (2002) [Pubmed]
  24. Favorable role of interleukin 10 in patients with polymyalgia rheumatica. Straub, R.H., Herfarth, H.H., Rinkes, B., Konecna, L., Glück, T., von Landenberg, P., Georgi, J., Helmke, K., Schölmerich, J., Vaith, P., Lang, B. J. Rheumatol. (1999) [Pubmed]
  25. Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica. Pulsatelli, L., Meliconi, R., Boiardi, L., Macchioni, P., Salvarani, C., Facchini, A. Clinical and experimental rheumatology. (1998) [Pubmed]
  26. HLA antigens in polymyalgia rheumatica in northern Sweden. Uddhammar, A., Sojka, B.N., Rantapää-Dahlqvist, S. Clin. Rheumatol. (1996) [Pubmed]
  27. Polymyalgia rheumatica and temporal arteritis in blacks--clinical features and HLA typing. Sanford, R.G., Berney, S.N. J. Rheumatol. (1977) [Pubmed]
  28. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. McGonagle, D., Pease, C., Marzo-Ortega, H., O'Connor, P., Gibbon, W., Emery, P. J. Rheumatol. (2001) [Pubmed]
  29. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. Adachi, J., Cranney, A., Goldsmith, C.H., Bensen, W.G., Bianchi, F., Cividino, A., Craig, G.L., Kaminska, E., Sebaldt, R.J., Papaioannou, A. J. Rheumatol. (1994) [Pubmed]
  30. Ultrasonography of the glenohumeral joints--a helpful instrument in differentiation in elderly onset rheumatoid arthritis and polymyalgia rheumatica. Lange, U., Piegsa, M., Teichmann, J., Neeck, G. Rheumatol. Int. (2000) [Pubmed]
  31. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Reid, D.M., Nicoll, J.J., Smith, M.A., Higgins, B., Tothill, P., Nuki, G. British medical journal (Clinical research ed.) (1986) [Pubmed]
WikiGenes - Universities